Newsflash:
- Many Drug Labels Missing Dose, Safety Info for Kids
- Lilly Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer
- J&J Opens Doxil Rationing Program to New Patients
- FDA Issues Safety Label Changes for Fingolimod
- FDA Backs Pill to Block HIV Infection
- FDA Advisers Recommend Approving Arena Weight-Loss Drug
Antidepressant Use Linked to Increased Pulmonary Hypertension Risk in Infants
New York Times (01/13/12) Dell'Antonia, KJ
A study published in the British Medical Journal provides stronger evidence that taking some antidepressants during pregnancy doubles the risk of a baby developing pulmonary hypertension. The research, based on 1.6 million births in Denmark, Finland, Iceland, Norway or Sweden from 1996 to 2007, showed that among women using selective serotonin reuptake inhibitors, the risk of persistent pulmonary hypertension for infants more than doubled (particularly for use late in pregnancy).
Abstract News © Copyright 2011
INFORMATION, INC.
Sponsor Highlights
Our Sponsors:
Sitemap
© Pharmacist e-Link
